Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Roswell Park Cancer Institute
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
Yale University
University of California, San Francisco
Fred Hutchinson Cancer Center